Review




Structured Review

IonOptix fluoroplex tissue bath fluorometry system
Endosomolytic nanoplex delivery system enhances the delivery of p-HSP20 and inhibition of contraction. Rings of rat aorta were suspended in a <t>FluoroPlex</t> Tissue Bath Fluorometry System that can measure contraction and intracellular calcium concentration simultaneously. Rings were untreated (control), treated with different doses of the p-HSP20 peptide alone (100, 500, and 1000 μM), or peptide-nanoplex formulations (100, 200, and 500 μM), and inhibition of contraction and calcium concentration were measured. (A) Representative tracing showing contraction with PE and inhibition of contraction with p-HSP20 NP. (B) Cumulative data demonstrating enhanced inhibition of contraction with p-HSP20 or p-HSP20 NP. (C) Representative tracing showing inhibition of contraction and intracellular calcium concentration with 500 μM p-HSP20 NP (500 μM polyplex). (D) Cumulative data showing percent inhibition of contraction (force) and intracellular calcium concentration ([Ca2+]i). A fivefold increase in peptide mediated bioactivity was observed when delivered through the endosomolytic NP formulation compared to peptide alone without any change in the [Ca2+]i. *p<0.05, **p<0.001, ****p<0.00001, n = 4–6 (one-way ANOVA). p-HSP20 NP, p-HSP20 nanoplex.
Fluoroplex Tissue Bath Fluorometry System, supplied by IonOptix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluoroplex tissue bath fluorometry system/product/IonOptix
Average 90 stars, based on 1 article reviews
fluoroplex tissue bath fluorometry system - by Bioz Stars, 2026-04
90/100 stars

Images

1) Product Images from "Nanotechnology Enabled Modulation of Signaling Pathways Affects Physiologic Responses in Intact Vascular Tissue"

Article Title: Nanotechnology Enabled Modulation of Signaling Pathways Affects Physiologic Responses in Intact Vascular Tissue

Journal: Tissue Engineering. Part A

doi: 10.1089/ten.tea.2018.0169

Endosomolytic nanoplex delivery system enhances the delivery of p-HSP20 and inhibition of contraction. Rings of rat aorta were suspended in a FluoroPlex Tissue Bath Fluorometry System that can measure contraction and intracellular calcium concentration simultaneously. Rings were untreated (control), treated with different doses of the p-HSP20 peptide alone (100, 500, and 1000 μM), or peptide-nanoplex formulations (100, 200, and 500 μM), and inhibition of contraction and calcium concentration were measured. (A) Representative tracing showing contraction with PE and inhibition of contraction with p-HSP20 NP. (B) Cumulative data demonstrating enhanced inhibition of contraction with p-HSP20 or p-HSP20 NP. (C) Representative tracing showing inhibition of contraction and intracellular calcium concentration with 500 μM p-HSP20 NP (500 μM polyplex). (D) Cumulative data showing percent inhibition of contraction (force) and intracellular calcium concentration ([Ca2+]i). A fivefold increase in peptide mediated bioactivity was observed when delivered through the endosomolytic NP formulation compared to peptide alone without any change in the [Ca2+]i. *p<0.05, **p<0.001, ****p<0.00001, n = 4–6 (one-way ANOVA). p-HSP20 NP, p-HSP20 nanoplex.
Figure Legend Snippet: Endosomolytic nanoplex delivery system enhances the delivery of p-HSP20 and inhibition of contraction. Rings of rat aorta were suspended in a FluoroPlex Tissue Bath Fluorometry System that can measure contraction and intracellular calcium concentration simultaneously. Rings were untreated (control), treated with different doses of the p-HSP20 peptide alone (100, 500, and 1000 μM), or peptide-nanoplex formulations (100, 200, and 500 μM), and inhibition of contraction and calcium concentration were measured. (A) Representative tracing showing contraction with PE and inhibition of contraction with p-HSP20 NP. (B) Cumulative data demonstrating enhanced inhibition of contraction with p-HSP20 or p-HSP20 NP. (C) Representative tracing showing inhibition of contraction and intracellular calcium concentration with 500 μM p-HSP20 NP (500 μM polyplex). (D) Cumulative data showing percent inhibition of contraction (force) and intracellular calcium concentration ([Ca2+]i). A fivefold increase in peptide mediated bioactivity was observed when delivered through the endosomolytic NP formulation compared to peptide alone without any change in the [Ca2+]i. *p<0.05, **p<0.001, ****p<0.00001, n = 4–6 (one-way ANOVA). p-HSP20 NP, p-HSP20 nanoplex.

Techniques Used: Inhibition, Concentration Assay



Similar Products

90
Radnoti LLC fluoroplex tissue bath fluorometry system
Fluoroplex Tissue Bath Fluorometry System, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluoroplex tissue bath fluorometry system/product/Radnoti LLC
Average 90 stars, based on 1 article reviews
fluoroplex tissue bath fluorometry system - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
IonOptix fluoroplex tissue bath fluorometry system
Endosomolytic nanoplex delivery system enhances the delivery of p-HSP20 and inhibition of contraction. Rings of rat aorta were suspended in a <t>FluoroPlex</t> Tissue Bath Fluorometry System that can measure contraction and intracellular calcium concentration simultaneously. Rings were untreated (control), treated with different doses of the p-HSP20 peptide alone (100, 500, and 1000 μM), or peptide-nanoplex formulations (100, 200, and 500 μM), and inhibition of contraction and calcium concentration were measured. (A) Representative tracing showing contraction with PE and inhibition of contraction with p-HSP20 NP. (B) Cumulative data demonstrating enhanced inhibition of contraction with p-HSP20 or p-HSP20 NP. (C) Representative tracing showing inhibition of contraction and intracellular calcium concentration with 500 μM p-HSP20 NP (500 μM polyplex). (D) Cumulative data showing percent inhibition of contraction (force) and intracellular calcium concentration ([Ca2+]i). A fivefold increase in peptide mediated bioactivity was observed when delivered through the endosomolytic NP formulation compared to peptide alone without any change in the [Ca2+]i. *p<0.05, **p<0.001, ****p<0.00001, n = 4–6 (one-way ANOVA). p-HSP20 NP, p-HSP20 nanoplex.
Fluoroplex Tissue Bath Fluorometry System, supplied by IonOptix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fluoroplex tissue bath fluorometry system/product/IonOptix
Average 90 stars, based on 1 article reviews
fluoroplex tissue bath fluorometry system - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
IonOptix tissue bath fluorometry system fluoroplex
Endosomolytic nanoplex delivery system enhances the delivery of p-HSP20 and inhibition of contraction. Rings of rat aorta were suspended in a <t>FluoroPlex</t> Tissue Bath Fluorometry System that can measure contraction and intracellular calcium concentration simultaneously. Rings were untreated (control), treated with different doses of the p-HSP20 peptide alone (100, 500, and 1000 μM), or peptide-nanoplex formulations (100, 200, and 500 μM), and inhibition of contraction and calcium concentration were measured. (A) Representative tracing showing contraction with PE and inhibition of contraction with p-HSP20 NP. (B) Cumulative data demonstrating enhanced inhibition of contraction with p-HSP20 or p-HSP20 NP. (C) Representative tracing showing inhibition of contraction and intracellular calcium concentration with 500 μM p-HSP20 NP (500 μM polyplex). (D) Cumulative data showing percent inhibition of contraction (force) and intracellular calcium concentration ([Ca2+]i). A fivefold increase in peptide mediated bioactivity was observed when delivered through the endosomolytic NP formulation compared to peptide alone without any change in the [Ca2+]i. *p<0.05, **p<0.001, ****p<0.00001, n = 4–6 (one-way ANOVA). p-HSP20 NP, p-HSP20 nanoplex.
Tissue Bath Fluorometry System Fluoroplex, supplied by IonOptix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tissue bath fluorometry system fluoroplex/product/IonOptix
Average 90 stars, based on 1 article reviews
tissue bath fluorometry system fluoroplex - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Endosomolytic nanoplex delivery system enhances the delivery of p-HSP20 and inhibition of contraction. Rings of rat aorta were suspended in a FluoroPlex Tissue Bath Fluorometry System that can measure contraction and intracellular calcium concentration simultaneously. Rings were untreated (control), treated with different doses of the p-HSP20 peptide alone (100, 500, and 1000 μM), or peptide-nanoplex formulations (100, 200, and 500 μM), and inhibition of contraction and calcium concentration were measured. (A) Representative tracing showing contraction with PE and inhibition of contraction with p-HSP20 NP. (B) Cumulative data demonstrating enhanced inhibition of contraction with p-HSP20 or p-HSP20 NP. (C) Representative tracing showing inhibition of contraction and intracellular calcium concentration with 500 μM p-HSP20 NP (500 μM polyplex). (D) Cumulative data showing percent inhibition of contraction (force) and intracellular calcium concentration ([Ca2+]i). A fivefold increase in peptide mediated bioactivity was observed when delivered through the endosomolytic NP formulation compared to peptide alone without any change in the [Ca2+]i. *p<0.05, **p<0.001, ****p<0.00001, n = 4–6 (one-way ANOVA). p-HSP20 NP, p-HSP20 nanoplex.

Journal: Tissue Engineering. Part A

Article Title: Nanotechnology Enabled Modulation of Signaling Pathways Affects Physiologic Responses in Intact Vascular Tissue

doi: 10.1089/ten.tea.2018.0169

Figure Lengend Snippet: Endosomolytic nanoplex delivery system enhances the delivery of p-HSP20 and inhibition of contraction. Rings of rat aorta were suspended in a FluoroPlex Tissue Bath Fluorometry System that can measure contraction and intracellular calcium concentration simultaneously. Rings were untreated (control), treated with different doses of the p-HSP20 peptide alone (100, 500, and 1000 μM), or peptide-nanoplex formulations (100, 200, and 500 μM), and inhibition of contraction and calcium concentration were measured. (A) Representative tracing showing contraction with PE and inhibition of contraction with p-HSP20 NP. (B) Cumulative data demonstrating enhanced inhibition of contraction with p-HSP20 or p-HSP20 NP. (C) Representative tracing showing inhibition of contraction and intracellular calcium concentration with 500 μM p-HSP20 NP (500 μM polyplex). (D) Cumulative data showing percent inhibition of contraction (force) and intracellular calcium concentration ([Ca2+]i). A fivefold increase in peptide mediated bioactivity was observed when delivered through the endosomolytic NP formulation compared to peptide alone without any change in the [Ca2+]i. *p<0.05, **p<0.001, ****p<0.00001, n = 4–6 (one-way ANOVA). p-HSP20 NP, p-HSP20 nanoplex.

Article Snippet: Rings of rat aorta were suspended on hooks in a FluoroPlex Tissue Bath Fluorometry System (IonOptix LLC, Milton, MA and Radnoti Glass Technology, Inc., Monrovia, CA), which enables fluorescence ion recording in parallel with force measurement.

Techniques: Inhibition, Concentration Assay